|
|
 |
|
Viewing report
|
|
|
|
Urge Urinary Incontinence - Poor Differentiation Limiting New Product Uptake
Datamonitor, April 2006, Pages: 42
Urge urinary incontinence (UUI) is a relatively common disorder which can affect all age groups but becomes increasingly prevalent with old age. Although several pharmacological therapies are available for treating this distressing condition, patients reluctance to present to a physician and incorrect diagnosis of the different overactive bladder subtypes limit the potential of this market.
Scope of this title:
- Quantitative treatment data from 418 physicians based in US, Japan, France, Germany, Italy, Spain and UK; supported by key opinion leader comments
- Analysis of epidemiology, presentation and referral patterns, diagnostic assessment, and first- to third-line treatments for UUI
- Influences on treatment choice and perception of current drug therapies including tolterodine, oxybutynin, darifenacin and solifenacin
- Evaluation of unmet needs and future outlook including awareness of R&D drug pipeline
Highlights of this title:
Although the prevalence of UUI in women is high, the potential of this market is limited by the reluctance of patients to present to a physician for treatment. Direct to consumer advertising, where available, has already increased awareness and presentation of this condition but other strategies are also required to assist in enlarging the market.
In theory, UUI could be managed successfully by PCPs. However, there is little belief in their ability to correctly diagnose the subtypes of OAB and this lack of confidence is supported by inappropriate prescribing trends by PCPs. Methods to address diagnosis and treatment of UUI in the primary care setting should reflect the priorities of PCPs.
Older treatments for UUI are associated with a number of unpleasant side effects, leaving significant unmet need in this market. Several new products have recently entered the market yet there is little perceived differentiation from existing treatments. Emphasizing the improved efficacy and side effect profiles is key to improving uptake.
Reasons to order your copy:
- Forecast product sales by understanding key aspects of UUI epidemiology, diagnosis and treatment
- Gain a better understanding of the challenges facing current and future players in the UUI market
- Identify physicians’ key concerns in UUI including unmet needs and the attributes that physicians believe are desirable for future treatments
Customers who bought this item also bought
Mixed Urinary Incontinence - An Opportunity for Novel Drug Therapies
Management of Urinary Incontinence and Overactive Bladder - A Global Overview
European Urinary Incontinence Therapeutics Markets
Target Product Profiles 2008: Physician Insights on Key Attributes - Urge Urinary Incontinence
Stress Urinary Incontinence - Opinion Divided on Drug Therapy
Urinary Incontinence: Major Milestones
Pipeline and Commercial Insight: Urinary Incontinence - Lifecycle management strategies retain mid-term market growth
Trends and Developments in the European Urinary Incontinence
Urinary Incontinence Devices Market: An Analysis
Urinary Incontinence: Market Update - Growing Market Brings Opportunities for New Drugs
Dry Overactive Bladder - A Precursor to Wet Overactive Bladder?
Osteoarthritis - Preconceptions Damage Awareness and Treatments
|
|
|
|
